Wednesday, June 30, 2021 11:20:33 AM
The part that is most intriguing to me is the part that sounded like the auxiliary group performed outstanding with clear efficacy.
Because the obvious purpose of that arm is to make sure nobody is cheating.
So by the sounds of things, if that's right, then we should be good to go, new doors to open with this tech, and maybe only a $7B/yr concern, but that's not too bad, for now.
Making a dent in this cancer thing is a big deal.
I have little reason to believe with what they've said that we can expect the over all test/control comparison to come up to what they've said about the sub-group.
Just remember though we can make it on secondary measures alone, and there is reason to believe that is going to be good.
The data, so far, also seems to suggest the theory is correct, put immunotherapy before Chemo ( if not eliminate chemo altogether )
Mustard Gas can't be good
Why not just use chlorine
Because the obvious purpose of that arm is to make sure nobody is cheating.
So by the sounds of things, if that's right, then we should be good to go, new doors to open with this tech, and maybe only a $7B/yr concern, but that's not too bad, for now.
Making a dent in this cancer thing is a big deal.
I have little reason to believe with what they've said that we can expect the over all test/control comparison to come up to what they've said about the sub-group.
Just remember though we can make it on secondary measures alone, and there is reason to believe that is going to be good.
The data, so far, also seems to suggest the theory is correct, put immunotherapy before Chemo ( if not eliminate chemo altogether )
Mustard Gas can't be good
Why not just use chlorine
Recent CVM News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/17/2026 09:07:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 11:03:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 10:59:38 AM
- CEL-SCI Reports Fiscal First Quarter 2026 Results • Business Wire • 02/18/2026 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 10:01:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2026 01:23:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:30:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:26:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:23:02 PM
- CEL-SCI Reports Fiscal 2025 Results • Business Wire • 12/29/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 01:48:04 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/04/2025 05:15:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2025 10:00:37 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/07/2025 09:31:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2025 09:31:28 PM
- CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025 • Newsfile • 10/20/2025 01:00:00 PM
- CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference • Newsfile • 10/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2025 08:01:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2025 07:57:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2025 07:46:01 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/29/2025 08:16:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2025 05:15:44 PM
- CEL-SCI Announces Closing of $10 Million Public Offering • Business Wire • 08/29/2025 04:52:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/28/2025 08:24:34 PM
